CCND1 and breast cancer: The administration of nano-curcumin has been shown to reduce the expression of the Cyclin D1 and DILA1 genes, as well as downregulate the PI3K/AKT/mTOR signaling pathway, and furthermore, induce apoptosis in tamoxifen-resistant breast cancer cells (Fig 7).